Mary Miller Acrivon Therapeutics, Inc. (ACRV) insider trading activity

Shares Held (Direct Ownership) 39K

1.87% 3M change

12.01% 12M change

Total Value Held N/A

Mary Miller Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 14 2024	SELL Payment of exercise price or tax liability	$1,291 $7.02 p/Share	184 Reduced 0.47%	38,967 Common Stock
Jul 17 2024	SELL Payment of exercise price or tax liability	$4,291 $7.69 p/Share	558 Reduced 1.41%	39,151 Common Stock
May 14 2024	SELL Payment of exercise price or tax liability	$1,538 $8.36 p/Share	184 Reduced 0.46%	39,709 Common Stock
Apr 17 2024	SELL Payment of exercise price or tax liability	$5,769 $10.34 p/Share	558 Reduced 1.38%	39,893 Common Stock
Feb 14 2024	SELL Payment of exercise price or tax liability	$737 $3.4 p/Share	217 Reduced 0.53%	40,451 Common Stock
Jan 17 2024	SELL Payment of exercise price or tax liability	$2,836 $4.35 p/Share	652 Reduced 1.58%	40,668 Common Stock
Nov 14 2023	SELL Payment of exercise price or tax liability	$3,733 $5.08 p/Share	735 Reduced 1.75%	41,320 Common Stock
Oct 17 2023	SELL Payment of exercise price or tax liability	$12,231 $5.48 p/Share	2,232 Reduced 5.04%	42,055 Common Stock
Sep 26 2023	BUY Grant, award, or other acquisition	-	3,858 Added 8.01%	44,287 Common Stock

BFLY

Butterfly Network, Inc. Healthcare

General Counsel & Corp Sec

Chief Legal Officer

Guilford, CT

Receive a notification when an Institution or Guru buys or sells ACRV shares.

Notify only if

Value

Get notified when an Acrivon Therapeutics, Inc. insider buys or sells ACRV shares.

Notify only if

Operation

Value

Type

Receive news related to Acrivon Therapeutics, Inc.